Nisa Investment Advisors, LLC Fate Therapeutics Inc Transaction History

Nisa Investment Advisors, LLC

  • $16.7 Billion
  • Q3 2024

A detailed history of Nisa Investment Advisors, LLC transactions in Fate Therapeutics Inc stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 17,151 shares of FATE stock, worth $45,964. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17,151
Previous 17,502 2.01%
Holding current value
$45,964
Previous $57,000 5.26%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024
SELL
$3.12 - $5.57 $1,095 - $1,955
-351 Reduced 2.01%
17,151 $60,000
Q2 2024

Jul 19, 2024
BUY
$3.26 - $7.08 $1,189 - $2,584
365 Added 2.13%
17,502 $57,000
Q1 2024

May 01, 2024
BUY
$3.54 - $8.35 $1,051 - $2,479
297 Added 1.76%
17,137 $125,000
Q4 2023

Jan 25, 2024
BUY
$1.65 - $3.94 $25,410 - $60,676
15,400 Added 1069.44%
16,840 $62,000
Q3 2023

Nov 02, 2023
SELL
$2.02 - $5.04 $220 - $549
-109 Reduced 7.04%
1,440 $3,000
Q2 2023

Aug 11, 2023
SELL
$4.76 - $6.59 $18,830 - $26,070
-3,956 Reduced 71.86%
1,549 $7,000
Q1 2023

May 02, 2023
BUY
$4.24 - $11.12 $22,069 - $57,879
5,205 Added 1735.0%
5,505 $31,000
Q4 2022

Feb 02, 2023
SELL
$9.86 - $23.83 $21,317 - $51,520
-2,162 Reduced 87.81%
300 $3,000
Q3 2022

Nov 07, 2022
BUY
$21.04 - $36.06 $7,616 - $13,053
362 Added 17.24%
2,462 $51,000
Q2 2022

Aug 03, 2022
SELL
$17.78 - $42.39 $4,622 - $11,021
-260 Reduced 11.02%
2,100 $52,000
Q1 2022

Apr 29, 2022
SELL
$29.67 - $60.28 $5,340 - $10,850
-180 Reduced 7.09%
2,360 $91,000
Q4 2021

Feb 03, 2022
SELL
$47.84 - $64.34 $17,222 - $23,162
-360 Reduced 12.41%
2,540 $105,000
Q3 2021

Oct 18, 2021
SELL
$59.27 - $95.73 $11,854 - $19,146
-200 Reduced 6.45%
2,900 $172,000
Q2 2021

Aug 06, 2021
SELL
$67.25 - $92.52 $28,917 - $39,783
-430 Reduced 12.18%
3,100 $269,000
Q1 2021

Apr 26, 2021
SELL
$72.16 - $117.4 $28,864 - $46,960
-400 Reduced 10.18%
3,530 $291,000
Q4 2020

Jan 25, 2021
BUY
$38.09 - $100.95 $56,182 - $148,901
1,475 Added 60.08%
3,930 $357,000
Q3 2020

Oct 20, 2020
BUY
$30.41 - $40.5 $57,779 - $76,950
1,900 Added 342.34%
2,455 $98,000
Q2 2020

Jul 27, 2020
BUY
$20.21 - $35.23 $606 - $1,056
30 Added 5.71%
555 $19,000
Q1 2020

Apr 17, 2020
SELL
$17.28 - $31.88 $1,296 - $2,391
-75 Reduced 12.5%
525 $12,000
Q3 2019

Oct 17, 2019
BUY
$15.47 - $22.5 $2,629 - $3,825
170 Added 39.53%
600 $9,000
Q3 2018

Oct 16, 2018
BUY
$8.75 - $16.29 $3,762 - $7,004
430 New
430 $7,000

Others Institutions Holding FATE

# of Institutions
175
Shares Held
115M
Call Options Held
53.7K
Put Options Held
9K
View Full List

About FATE THERAPEUTICS INC

FATE Quotes by TradingView
  • Ticker FATE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,000,304
  • Market Cap $260M
  • Description
  • Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...
More about FATE
Track This Portfolio

Track Nisa Investment Advisors, LLC Portfolio

Follow Nisa Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email